关注
Aureliano Stingi
Aureliano Stingi
未知所在单位机构
在 medendi.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
V Audrito, S Serra, A Stingi, F Orso, F Gaudino, C Bologna, F Neri, ...
Oncotarget 8 (9), 15894, 2017
1022017
Nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic target in BRAF-mutated metastatic melanoma
V Audrito, A Managò, S La Vecchia, F Zamporlini, N Vitale, G Baroni, ...
JNCI: Journal of the National Cancer Institute 110 (3), 290-303, 2018
462018
SARS‐CoV‐2 infection and cancer: Evidence for and against a role of SARS‐CoV‐2 in cancer onset
A Stingi, L Cirillo
BioEssays 43 (8), 2000289, 2021
242021
Up-regulation of PD-L1 in melanoma determines resistance to BRAF and MEK inhibitors, induces a more aggressive phenotype and is partially mediated through post-transcriptional …
D Brusa, A Stingi, V Audrito, F Orso, S Serra, R Buonincontri, F Neri, ...
Cancer Research 76 (14_Supplement), 241-241, 2016
2016
Investigating the mitotic role of Retinoblastoma protein and its impact on chromosomal instability
A Stingi
系统目前无法执行此操作,请稍后再试。
文章 1–5